The effect of iloprost on pulmonary hypertension and exercuse capacity

The effect of iloprost on pulmonary hypertension and exercuse capacity - Iloprost for Pulmonary Hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027284

Enrollment

Registered

2017-07-01

Start date

2017-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary arterial hypertension

Interventions

inhale of iloprost

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pulmonary arteril hypertension

Exclusion criteria

Exclusion criteria: Unstable hemodynamics

Design outcomes

Primary

Measure	Time frame
Hemodynamics and the results of 6MDW and CVD events	—

Countries

Japan

Contacts

Public ContactShusuke Yagi

The University of Tokushima Graduate School of Health Biosciences Department of Community Medicine and Human Resource Development

syagi@tokushima-u.ac.jp088-633-7851

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026